A carregar...
Emerging Reverse Transcriptase Inhibitors for HIV-1 Infection
INTRODUCTION: There are 36.7 million people living with HIV with 20.9 million having access to antiretroviral therapy (ART). Nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs) remain the ‘backbone’ of ART. However, the currently available nine NRTIs and five non-nucleoside reverse transc...
Na minha lista:
| Publicado no: | Expert Opin Emerg Drugs |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6158299/ https://ncbi.nlm.nih.gov/pubmed/29737220 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/14728214.2018.1474202 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|